Jefferies maintains Aehr Test System at Buy, lowers price target to $140 from $175

What happened

Jefferies kept its Buy rating on Aehr Test System but cut its price target to $140 from $175, a 20.0% decrease. That target implies 172.0% upside from the November 2 close of $51.47.

Confirmed

Global impact / market context

A lower target still far above the current share price suggests the analyst sees big potential but less than before. Investors reading this may question what changed in their view of future sales or profit.

Analyst inference

A price target is an analyst's estimate of where a stock could trade. Cutting it by a fifth while keeping a Buy rating signals reduced expectations rather than a negative view of the company.

Analyst inference

What to watch

1. The article states the new target implies 172.0% upside from the November 2 close of $51.47, so future share prices can be compared with that reference point. Confirmed
2. Watch whether other analysts also lower their price targets for Aehr Test System, which would suggest a broader change in expectations across the industry. Analyst inference
3. Watch for company updates on customer orders and costs, since weaker demand or higher expenses could explain why the analyst reduced the expected upside. Proposed

Evidence

• Original source link unavailable